In this interview, News Med is talking to Gabriela Saldanha about DNA Fragmentation and Sanger Sequencing. What are Sanger sequencing and DNA-fragment analysis? Where are these analyses used? Sanger ...

MADISON, Wis.--(BUSINESS WIRE)--Research labs performing Sanger sequencing can now use Promega chemistry on any capillary electrophoresis (CE) platform. The ProDye™ Terminator Sequencing System, ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific ...

In 1997, Sanger, Nicklen and Coulson described a method for determining DNA nucleotide sequences. 1 Nearly five decades later, Sanger sequencing remains an entrenched technology for targeted ...

In this Tech Blast episode, Jay Lemke, Senior Research Scientist at Promega, provides a brief overview of Sanger sequencing, its history, working principle and development over the last half century.

Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic variations ...

Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic variations ...

This image compares three DNA sequencing technologies: Sanger sequencing, Massively Parallel DNA sequencing, and Nanopore DNA sequencing. Sanger sequencing (left) sequences 500-700 bases per reaction ...

Sanger sequencing has been the powerhouse of DNA sequencing since it was invented by Frederick Sanger in 1977, a creation for which he won his second Nobel Prize in Chemistry in 1980. There have been ...

DNA sequencing has a remarkable history, in terms of inception and evolution of the technologies themselves, as well as the breadth and scope of problems to which they have been applied. This Nature ...

A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA ...